Acanthamoeba encystment: multifactorial effects of buffers, biocides, and demulcents present in contact lens care solutions
Authors Kovacs C, Lynch S, Rah M, Millard K, Morris T
Received 8 May 2015
Accepted for publication 23 July 2015
Published 13 October 2015 Volume 2015:9 Pages 1905—1913
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Yang Liu
Peer reviewer comments 4
Editor who approved publication: Dr Scott Fraser
Christopher J Kovacs, Shawn C Lynch, Marjorie J Rah, Kimberly A Millard, Timothy W Morris
Bausch & Lomb Incorporated, Rochester, NY, USA
Purpose: To determine whether agents which are purportedly capable of inducing encystment of Acanthamoeba can recapitulate the signal when tested in differing formulations.
Methods: In accordance with the International Standard ISO 19045, Acanthamoeba castellanii ATCC 50370 trophozoites were cultured in antibiotic-free axenic medium, treated with test solutions, and encystment rates plus viability were measured via bright field and fluorescent microscopy. Test solutions included phosphate-buffered saline (PBS), borate-buffered saline, biguanide- and hydrogen peroxide (H2O2)-based biocides, propylene glycol (PG) and povidone (POV) ophthalmic demulcents, and one-step H2O2-based contact lens disinfection systems.
Results: Only PBS solutions with 0.25 ppm polyaminopropyl biguanide (PAPB) and increasing concentrations of PG and POV stimulated A. castellanii encystment in a dose-dependent manner, whereas PBS solutions containing 3% H2O2 and increasing concentrations of PG and POV did not stimulate encystment. Borate-buffered saline and PBS/citrate solutions containing PG also did not stimulate encystment. In addition, no encystment was observed after 24 hours, 7 days, or 14 days of exposures of trophozoites to one-step H2O2 contact lens disinfection products or related solutions.
Conclusion: The lack of any encystment observed when trophozoites were treated with existing or new one-step H2O2 contact lens care products, as well as when trophozoites were exposed to various related test solutions, confirms that Acanthamoeba encystment is a complex process which depends upon simultaneous contributions of multiple factors including buffers, biocides, and demulcents.
Keywords: propylene glycol, contact lens care system, hydrogen peroxide disinfecting solution
Acanthamoeba protozoa are ubiquitous pathogens found in both soil and aquatic environments, man-made structures and can also reside in healthy organisms.1,2 They are capable of causing a variety of human infections, including granulomatous amebic encephalitis in immune-compromised individuals, which affects the central nervous system and is often fatal.1 Acanthamoeba have been shown to serve as a reservoir for Legionella, with these bacteria persisting as endosymbionts within the amoebae, leading to the hypothesis that outbreaks of Legionnaire’s disease may be directly related to presence of the Acanthamoeba.3 In healthy (ie, immune-competent) patients, Acanthamoeba spp. can also cause Acanthamoeba keratitis (AK), a painful infection of the cornea which can result in severe and permanent visual impairment, including blindness.4 The incidence of AK among contact lens wearers in the USA has historically been low, with estimates of one to two cases per million users.5 Approximately 80%–90%6 of AK infections occur among contact lens wearers, however, with additional risk factors associated with noncompliance, such as improper storage and handling, as well as swimming or showering while wearing lenses.4 An increase in confirmed AK cases was observed at the beginning of 2004 and ultimately was linked to patients using the multipurpose contact lens cleaning solution Complete® MoisturePlus™ (CMP), resulting in its voluntary recall by Advanced Medical Optics in May 2007.7 The association of AK cases with CMP users was proposed to be due to stimulation of Acanthamoeba encystment observed following exposure to the CMP solution.8
Under conditions of environmental stress such as starvation and desiccation, Acanthamoeba trophozoites undergo transformation into a double-walled resistant cyst that is capable of remaining dormant, yet viable, until conditions favorable for growth return. This encystment process is a natural component of the Acanthamoeba life cycle, and cyst forms have been shown to resist disinfection by heat, chlorination, and treatment with multipurpose contact lens disinfecting solutions.9–16 Kilvington et al showed that over 20% of Acanthamoeba trophozoites exposed to CMP solution for 24 hours in lab experiments transformed into immature cysts.8 This study concluded that the demulcent propylene glycol (PG) was a causative factor in the CMP solution which promoted encystment, while importantly noting that additional factors, such as the buffering system of the solution, may have also been involved.8 The hypothesized influence of other (ie, non-PG) factors is supported by the fact that many currently available ophthalmic products (including a variety of other contact lens disinfecting solutions, contact lens packaging solutions, and lubricating eye drops) contain PG and to date have not been associated with Acanthamoeba encystment.
Ophthalmic demulcents are typically water-soluble polymers which may be topically applied to the eye to protect and lubricate mucous membrane surfaces as well as to relieve dryness and irritation.17 Ophthalmic demulcents are also present in various lens care disinfecting solutions to provide enhanced lubrication. PG is a liquid polyol monographed ophthalmic demulcent that acts as a water-binding moisturizer that can hold nearly three times its weight in water.18 Similarly, the demulcent povidone (POV) can retain water while also lubricating the surfaces to which it binds. Both are approved for human use as active ingredients in over-the-counter ophthalmic products at concentrations ranging from 0.2% to 1.0% for PG and 0.2% to 2.0% for POV.17
Previous studies have investigated the contribution of PG in multipurpose solutions on Acanthamoeba encystment. Although one study concluded that PG was a primary factor in CMP solution-induced encystment,8 additional studies showed that solutions containing PG at similar concentrations did not stimulate encystment.19 Additionally, Acanthamoeba encystment has been shown to be influenced by different buffering agents.20 Furthermore, the impact of PG in H2O2-based disinfecting solutions has not been thoroughly studied. Given the previous studies showing PG as a causative factor of Acanthamoeba encystment plus the lack of similar testing for H2O2-based solutions,8 a series of model disinfecting solutions and commercially available lens care products were tested to directly assess the individual and combined impacts of different ophthalmic demulcents, chemical disinfectants, and buffering agents on Acanthamoeba encystment. The purpose of the study reported here was to determine whether agents which are purportedly capable of inducing encystment of Acanthamoeba can recapitulate the signal when tested in differing formulations. Such data have important implications for the development of contact lens disinfecting solutions concerning the types and concentrations of buffering agents and biocidal components to be used when considering Acanthamoeba encystment.
Materials and methods
Cultures and media
A. castellanii ATCC 50370 (American Type Culture Collection, Manassas, Virginia, USA) was thawed from cryopreserved ampoules and grown for 3–4 days at 28°C±2°C in semi-defined axenic AC#6 growth media lacking antibiotics. One day prior to testing, cells were passaged to fresh medium and incubated for an additional 20–24 hours at 28°C±2°C. Following outgrowth, trophozoites were dislodged, washed three times in quarter-strength Ringer’s solution (Oxoid BR0052G; Thermo Fisher Scientific, Waltham, MA, USA), and centrifuged at 500× g for 5 minutes at room temperature. Cells were counted using a disposable hemocytometer (C-chip Fuchs-Rosenthal DHC-F01, INCYTO; Drive Covington, GA, USA) and adjusted to 1.0×107 trophozoites/mL immediately before testing. Neutralization buffer for H2O2-containing solutions (AC#6-C) consisted of AC#6 media supplemented with 0.1% filter-sterilized bovine liver catalase (Sigma C40; Sigma-Aldrich Co, St Louis, MO, USA).
Table 1 provides a complete listing along with key composition details for each test solution. A positive encystment control solution was adapted from both our own studies and previous reported studies: phosphate buffered saline (PBS) solution containing polyaminopropyl biguanide (PAPB, also referred to as polyhexamethylene biguanide) and PG (PBS-PAPB-PG+).21 The non-buffer components of PBS-PAPB-PG+ were also formulated as a borate-buffered saline (BBS) solution containing PAPB and PG (BBS-PAPB-PG+) to investigate the role of different buffering agents. Two different ophthalmic demulcents, PG and POV, were added at their respective US Food and Drug Administration (FDA) monographed ranges17 into either PAPB or H2O2-containing solutions. A series of H2O2 concentrations (0%–3%) was also tested in the presence of 1% PG. A new one-step H2O2-based contact lens care product, PeroxiClear (PER-1; Bausch & Lomb, Rochester, NY, USA) was tested in parallel with another H2O2-based lens care product, Clear Care (PER-2; Alcon Laboratories, Fort Worth, TX, USA). Derivatives of the PER-1 solution which lacked PG, H2O2, or both (PER-1a, PER-1b, PER-1c, respectively) were also tested. Neutralization of H2O2-containing solutions was confirmed by measuring residual H2O2 levels using a Mettler Toledo T50 Autotitrator with a modified 4-hour method adapted from USP 38 monograph. The monograph describes a titrimetric system for assaying the concentration of hydrogen peroxide in a topical solution. The titrant used was 0.1 N potassium permanganate with the endpoint detected using Mettler Toledo LabX light titration, version 22.214.171.124. Each milliliter of the titrant used was equivalent to 1.701 mg of hydrogen peroxide. A modification of the sample size along with programming the software to automatically dispense the titrant at a controlled rate allowed for the detection of hydrogen peroxide at levels between 0 and 30,000 ppm.
Encystment rates for each solution were measured as described in International Standard ISO 19045:2015: Ophthalmic optics – contact lens care products – method for evaluating Acanthamoeba encystment by contact lens care products” (hereafter, “ISO 19045”),22 with modifications as needed to accommodate testing with one-step H2O2 disinfecting systems. Assays using solutions containing H2O2 were performed in manufacturer-provided neutralizing lens cases containing platinum discs which catalyze the conversion of H2O2 to H2O and O2. Lens cases were filled with 10 mL of test solution and inoculated to give a final concentration of 1.0×105 trophozoites/mL, then immediately capped and incubated at room temperature (20°C±2°C). At specified time points, the detergent sarkosyl (Sigma 61747; Sigma-Aldrich Co) was added to lens cases to lyse any remaining trophozoites, while the fluorescent stain calcofluor-white (Sigma F3543; Sigma-Aldrich Co), which binds to cellulose within cyst walls,23 was used to identify cysts. Exposure to the sarkosyl/calcofluor-white mixture (150 mg/10 mg per 1.0 mL in purified water) did not exceed 5 minutes to ensure that only trophozoites, and not cysts, would be lysed. Test solutions which lacked H2O2 were tested in multi-well plates containing 3 mL of test solution and inoculated to give a final concentration of 1.0×105 trophozoites/mL, and all other steps were performed as described earlier. Samples were enumerated using an Olympus BX51 upright epifluorescence microscope by comparing manual counts under bright field illumination to epifluorescence (excitation 350 nm/emission 460 nm). Rounded cellular bodies with bright white fluorescence were counted as cysts. Encystment was expressed as a percentage of cysts observed after solution exposure relative to inoculum control counts, corrected for background cyst count obtained at 0 hour. Final percentages were averaged from three independent assays. For encystment studies that were carried out to 14 days, viable amoebae were also determined as described later in this work.
To enumerate surviving amoebae after 14 days of incubation with test solutions, an agar overlay method24 was used, with modifications. Briefly, 1 mL samples were removed from lens cases after 14 days’ incubation and neutralized in AC#6-C for 10 minutes. Samples were again serially diluted (1:10) in AC#6-C, then pelleted by centrifugation at 1,000× g for 5 minutes and resuspended into 100 μL of neutralizing buffer. To this, 100 μL of Escherichia coli (ATCC 33876, 5.0×108/mL) and 3 mL of molten top agar (10.0 g tryptone; 5.0 g NaCl; 7.0 g Bacto™ agar (BD Biosciences 214010; BD Biosciences, San Jose, CA, USA) held at 45°C were added and vortexed to mix thoroughly. The top agar mixture was then poured onto solidified SM/5 agar plates (2.0 g proteose peptone, 2.0 g yeast extract, 2.0 g glucose, 2.0 g MgSO4, and 15.0 g Bacto agar in 1.0 L of purified H2O) and incubated at 28°C±2°C for 5 days. Viable amoebae were enumerated by counting visible plaques formed against a background of E. coli growth within the top agar, and recorded as plaque-forming units.
Stand-alone biocidal efficacy
Testing of one-step H2O2 disinfecting solutions was adapted from previously described methods.11,19 Independent duplicate assays were performed in new lens cases containing neutralizing platinum-coated discs. Lens cases were filled with 10 mL of either PER-1 or PER-2 and inoculated to give a final concentration of 5.0×104 trophozoites/mL, then immediately capped. At each time point, samples were neutralized with AC#6-C for 10 minutes, then serially diluted (1:10) in tubes containing AC#6-C. Aliquots from the dilutions were added to the wells of a 96-well plate and incubated at 28°C±2°C. Wells were then microscopically inspected over a 14-day outgrowth period for evidence of trophozoite growth and replication. Log10 reduction values were averaged from independent duplicate assays as determined by the most-probable number method using Spearman–Karber computations.25
All analyses were run using Minitab® 17.2.1 Statistical Software (Minitab Inc., State College, PA, USA); Bonett’s method was used to determine any statistical differences in variances between two-sample sets using an alpha =0.05. Any statistical differences in the variances were accounted for in the comparison of the mean values. Two-sample t-tests were used for comparing the means between the control and test sample sets at 95% confidence interval. If the P-value was less than or equal to 0.05, the means were considered to be significantly different between the two-sample sets.
Across multiple experiments, the positive encystment control solution PBS-PAPB-PG+ (containing 0.5% PG and 0.25 ppm PAPB in a phosphate-buffered system) consistently yielded encystment rates of ≥50% (Figures 1 and 2). To assess the influence of different buffering systems on A. castellanii encystment, the non-buffer system components of PBS-PAPB-PG+ were reformulated into a borate-buffered system – BBS-PAPB-PG+. After incubation with BBS-PAPB-PG+ for 24 hours, A. castellanii trophozoites did not encyst (Figure 1). The mean encystment rate of the control solution PBS-PAPB-PG+ was significantly higher than each of the test solutions (solution containing PBS and PAPB, without PG [PBS-PAPB-PG−], BBS-PAPB-PG+, and solution containing BBS and PAPB without PG [BBS-PAPB-PG−]) (P<0.05).
Next, a series of PBS/citrate-buffered solutions containing a concentration of 1.0% PG and a range of H2O2 concentrations from 0% to 3% were tested, none of which induced encystment of A. castellanii (Figure 2). The mean encystment rate of the positive control (PBS-PAPB-PG+) was significantly higher than all varying concentrations of H2O2 (P<0.05), while among the varying concentrations of H2O2, no significant differences were observed (P>0.05).
To assess A. castellanii encystment with regards to the addition of ophthalmic demulcents to model disinfecting solutions, phosphate-buffered solutions that contained either 0.25 ppm PAPB or 3% H2O2 were prepared. Both POV and PG were added to each at dose levels spanning their respective FDA monograph concentration ranges (POV: 0.0%–2.0%, PG: 0.0%–1.0%; monograph ophthalmic demulcent concentration ranges defined by the FDA Code of Federal Regulations for use in over-the-counter ophthalmic drug products).17 After 24 hours’ incubation, encystment rates for solutions containing 0.25 ppm PAPB increased in a dose-dependent manner for both PG and POV (88% and 14%, respectively, at their highest test concentration). For both PAPB and H2O2 test solutions, the mean encystment rates for different concentrations of POV and PG were compared to their respective base solution (ie, 0.0% POV or PG) (Figure 3). For the PAPB test solutions containing POV, only the formulation of 2.0% POV was significantly greater than the solution containing no (0.0%) POV (P<0.05). Mean encystment rates of PAPB test solutions containing PG were significantly greater than that of the PAPB solution without PG (0.0%) for all concentrations tested (P<0.05). Solutions containing 3% H2O2 did not induce encystment (ie, ≤1%) regardless of the presence or absence of demulcents. For all concentrations of POV with the H2O2 test solutions, the mean encystment rates were not significantly different from the solution containing no POV (P>0.05). Similarly, for the H2O2 test solutions containing PG, the mean encystment rate of the test solution containing a 0.0% concentration of PG was not significantly different than the test solution with increasing concentrations of PG (P>0.05).
Label instructions for the new one-step H2O2 disinfecting solution (PER-1) tested included simultaneous disinfection and neutralization with a minimum of a 4-hour soak time followed by storage of disinfected contact lenses for up to 7 days. Considering these storage instructions, the potential for encystment during a simulated long-term storage condition was tested as follows. When A. castellanii was added to PER-1 and its derivatives, PER-1a, PER-1b, and PER-1c (Table 1), and incubated for 24 hours, 7 days, or 14 days, encystment rates for all solutions at each time point were ≤2%, which was significantly less (P<0.05) than the positive control (Figure 4). Surviving cells from inoculated lens cases stored for 14 days were also enumerated with no recovery of Acanthamoeba observed for PER-1 and PER-1a solutions (both of which contained 3% H2O2), whereas 2,200 and 1,100 amoeba/mL, respectively, were recovered from PER-1b and PER-1c (both of which did not contain H2O2).
Finally, both of the one-step H2O2 lens care products – PER-1 and PER-2 – were evaluated for encystment effects as well as for stand-alone biocidal efficacy against A. castellanii trophozoites. Encystment rates for both products were <1% after 24 hours’ incubation, significantly (P<0.05) lower than the positive control solution (Figure 5A). Average log10 reduction results at 4, 6, and 24 hours were 4.3, 4.3, and 4.3, respectively, for PER-1, and 4.1, 4.2, and 4.1, respectively, for PER-2 (Figure 5B).
While standardized performance criteria are lacking for biocidal efficacy and encystment testing of Acanthamoeba, better understanding of the factors that contribute to the organism’s ability to evade treatment are needed for the development of improved contact lens care systems. The study presented here demonstrated that stimulation of A. castellanii encystment by model contact lens disinfecting solutions can be dependent upon multifactorial contributions from various solution components. Among the known factors, the buffering system and biocidal agents used in a solution were shown to directly influence encystment rates under some (but not all) test conditions. In addition, exposure of A. castellanii trophozoites to a variety of test solutions which contained PG (including a new H2O2-based contact lens disinfecting solution) did not stimulate encystment.
Previous studies have demonstrated that multipurpose solutions containing PG may stimulate Acanthamoeba encystment to varying degrees. In one study, CMP solution was reported to induce encystment at a rate of 20.8% in A. castellanii, while Menicare Soft and Epica Cold (both also containing PG) yielded only 1.2% and 2.4% cysts, respectively.8 Additionally, when several multipurpose solutions were supplemented with 0.5% PG, encystment rates were unaffected for some solutions, while for others, encystment rates slightly increased. Yet, in all instances, the rates remained much lower than those reported for the CMP solution.8 It has been suggested that these increases in encystment rates were due to increased osmolality resulting from the addition of PG to the solutions.19 Later studies by Lonnen et al confirmed the low levels of encystment previously observed in Menicare Soft and Epica Cold.19 However, a multipurpose solution which lacked PG was also shown to induce Acanthamoeba encystment. The authors hypothesized that this encystment in the absence of PG was potentially due to the phosphate buffer component of that test solution.19
A number of factors have been proposed to contribute to Acanthamoeba encystment associated with a solution, including osmolality,19,26 intrinsic biocidal activity,27 and buffering agents.8,19 Indeed, various multipurpose solutions that contain PG either do not induce encystment or result in much lower encystment rates than those observed with CMP solution.8 The phosphate-buffered positive control solution (PBS-PAPB-PG+) used in the present study, which contained PG, was compared to a model solution composed of the same ingredients at identical concentrations in a borate-buffered positive control solution – BBS-PAPB-PG+. Encystment was not observed after 24 hours’ incubation with BBS-PAPB-PG+, suggesting that the encystment signal observed in PBS-PAPB-PG+ can be attributed to the combined effects of the phosphate buffer and PG. In addition, the PER-1c solution (containing 1.0% PG in a PBS/citrate-buffered formulation without a biocidal agent) also did not induce encystment, even with prolonged incubation up to 14 days (Figure 5). Further, studies have also shown that Acanthamoeba culbertsoni encystment was inhibited by citrate buffer, while Tris buffer lysed trophozoites.20 Taken together, these results clearly demonstrate that encystment of Acanthamoeba spp. is mediated by the overall composition of a solution, including its buffering system in conjunction with other components.
PG is classified by the FDA as a liquid polyol demulcent, safe for use in over-the-counter products at concentrations ranging from 0.2% to 1.0%.17 Its primary function in contact lens disinfecting solutions is to provide enhanced lubrication and wettability of contact lenses. POV, another demulcent often present in eye drop formulations, is similarly approved for use at concentrations ranging from 0.2% to 2.0%.17 While neither demulcent has been shown to confer toxicity within its monograph concentration range, demulcents such as PG are capable of raising the osmolality of a solution. Indeed, hyperosmolality has been shown to cause encystment in pathogenic strains of Acanthamoeba.28 This was taken into consideration in the present study by controlling for osmolality and adjusting all test solutions to a specified osmolality target of 290–300 mOsm/kg, within the physiologically biocompatible range found in most commercially available contact lens care solutions. Here, the PG and POV demulcents showed a dose-dependent stimulation of encystment only when present in PBS-based solutions which also contained 0.25 ppm PAPB. When the same concentrations of PG and POV were instead present in PBS solutions containing 3% H2O2, neither demulcent stimulated encystment. While the intrinsic biocidal activity of H2O2 is typically very strong against Acanthamoeba trophozoites, it is important to note that the H2O2 experiments were carried out in neutralizing lens cases, where after 4 hours of incubation, the H2O2 levels were <100 ppm (data not shown). For encystment testing in this study, all solution exposures were for at least 24 hours, so unless complete kill had occurred during the initial 4 hours, there would still have been viable amoebae present and exposed to the PBS containing PG and POV for the remainder of the assay. Moreover, when the concentration of PG was held at a constant 1% and the concentration of H2O2 was dosed from 0% to 3%, again no encystment was detected for any concentration of H2O2 tested. This is particularly relevant for H2O2 concentrations substantially below 3% where biocidal activity is expected to be reduced. Specifically, if encystment stimulation by PG is dependent on a sublethal insult, it is possible that exposure to low (ie, less effective) levels of H2O2 could result in stimulation of encystment. However, this was not observed, thus further supporting the hypothesis that encystment is dependent on more than just individual components of a solution.
Labeling instructions for the H2O2-based products PER-1 and PER-2 indicate that contact lenses may be stored for up to 7 days following the initial 4-hour (PER-1) or 6-hour (PER-2) disinfection period. Therefore, we also examined the influence of prolonged storage up to 14 days on Acanthamoeba encystment using a variety of formulations with and without both 3% H2O2 and 1.0% PG components. No encystment was observed for any of these solutions after 24 hours’, 7 days’, or 14 days’ storage in H2O2-neutralizing lens cases (Figure 4). This is particularly notable given that one of these solutions lacked any H2O2 while still containing 1.0% PG. Similarly, no encystment was detected with other commercially available one-step H2O2 solutions also incubated for 24 hours, 7 days, and 14 days (data not shown). Enumeration of surviving Acanthamoeba after 14 days’ incubation in the lens case demonstrated that, as expected, the H2O2-containing solutions were highly effective (ie, near complete kill), while in contrast, substantial numbers of viable amoebae were recovered from solutions that lacked H2O2. Given that prolonged starvation is commonly used to create mature cysts in the laboratory, the recovery of viable amoebae with no evidence of encystment after 14 days is somewhat unexpected and warrants future investigation.
The ability of pathogenic Acanthamoeba to undergo encystment presents a particular challenge to lens care disinfecting systems because the cyst forms survive longer and are less susceptible to a variety of antimicrobial treatments.9,11–15 While the contribution (if any) of cyst forms to initiating AK infections remains unclear, a contact lens disinfecting solution that enhances encystment could potentially be problematic. Recent reports have suggested pseudocyst formation as an alternative stress response to encystment.29 Of note, pseudocyst formation was suggested to be caused by PG,30 although the testing and detection methods differed from those reported here. Per the ISO 19045 encystment standard,22 the cysts observed in our studies were not characterized as either pseudocysts or immature cysts; however, this distinction merits further study. In particular, it would be valuable to better understand the onset of these two reported cyst forms in order to delineate what differences may influence their respective formation, as well as any risk factors associated with these forms for contact lens-associated AK infections. Changes of trophozoites observed in the present study were shown to be greatly influenced by both buffering and biocidal components of the challenge solutions and demonstrate the importance of a whole system, rather than individual components, on Acanthamoeba encystment.
Overall, the results reported here confirm that encystment associated with PG exposure is dependent on multiple factors, including buffering agents and biocidal components, and that these additional factors should be considered as a whole when investigating encystment effects. Further examination of the biocidal agents commonly used in contact lens disinfecting solutions and their interactions with other ingredients (including multicomponent buffering systems) would provide a more comprehensive understanding of Acanthamoeba encystment. This knowledge could facilitate the rational invention and development of new contact lens care solutions with improved safety and efficacy.
The authors would like to thank Sara Irizarry for her contributions to the manuscript.
All authors were employees of Bausch & Lomb Incorporated at the time of this work. The authors report no other conflicts of interest in this work.
Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16(2):273–307.
Mergeryan H. The prevalence of Acanthamoeba in the human environment. Rev Infect Dis. 1991;13 Suppl 5:S390–S391.
Cirillo JD, Falkow S, Tompkins LS. Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion. Infect Immun. 1994;62(8):3254–3261.
Centers for Disease Control and Prevention (CDC). Acanthamoeba keratitis FAQs. Atlanta, GA: CDC; nd [August 21, 2012]. Available from: http://www.cdc.gov/parasites/acanthamoeba/gen_info/acanthamoeba_keratitis.html. Accessed March 27, 2014.
Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998;17(1):3–10.
Ross J, Roy SL, Mathers WD, et al. Clinical characteristics of Acanthamoeba keratitis infections in 28 states, 2008 to 2011. Cornea. 2014;33(2):161–168.
Verani JR, Lorick SA, Yoder JS, et al; Acanthamoeba Keratitis Investigation Team. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis. 2009;15(8):1236–1242.
Kilvington S, Heaselgrave W, Lally JM, Ambrus K, Powell H. Encystment of Acanthamoeba during incubation in multipurpose contact lens disinfectant solutions and experimental formulations. Eye Contact Lens. 2008;34(3):133–139.
Borazjani RN, Kilvington S. Efficacy of multipurpose solutions against Acanthamoeba species. Cont Lens Anterior Eye. 2005;28(4):169–175.
Coulon C, Collignon A, McDonnell G, Thomas V. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. J Clin Microbiol. 2010;48(8):2689–2697.
Hughes R, Kilvington S. Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrob Agents Chemother. 2001;45(7):2038–2043.
Khunkitti W, Lloyd D, Furr JR, Russell AD. Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility. J Infect. 1998;36(1):43–48.
Kilvington S, Lam A. Development of standardized methods for assessing biocidal efficacy of contact lens care solutions against Acanthamoeba trophozoites and cysts. Invest Ophthalmol Vis Sci. 2013;54(7):4527–4537.
Kobayashi T, Gibbon L, Mito T, Shiraishi A, Uno T, Ohashi Y. Efficacy of commercial soft contact lens disinfectant solutions against Acanthamoeba. Jpn J Ophthalmol. 2011;55(5):547–557.
Mowrey-McKee M, George M. Contact lens solution efficacy against Acanthamoeba castellani. Eye Contact Lens. 2007;33(5):211–215.
Storey MV, Winiecka-Krusnell J, Ashbolt NJ, Stenström TA. The efficacy of heat and chlorine treatment against thermotolerant Acanthamoebae and Legionellae. Scand J Infect Dis. 2004;36(9):656–662.
CRF - Code of Federal Regulations Title 21, Vol 5, Sec 349.12. Revised April 1, 2013. US Food and Drug Administration; US Department of Health & Human Services. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm. Accessed March 27, 2014.
Denick J, Hu Z, inventors; Bausch & Lomb Incorporated, assignee. Ophthalmic compositions including glycerin and propylene glycol. United States patent US EP0969812A1. 2000 Jan 12.
Lonnen J, Heaselgrave W, Nomachi M, Mori O, Santodomingo-Rubido J. Disinfection efficacy and encystment rate of soft contact lens multipurpose solutions against Acanthamoeba. Eye Contact Lens. 2010;36(1):26–32.
Srivastava DK, Shukla OP. Encystment of Acanthamoeba culbertsoni by organic effectors. Indian J Exp Biol. 1983;21(8):444–447.
Kilvington S, Lam A, Lonnen J. Development of a standardised method for the quantified determination of contact lens disinfectant efficacy against Acanthamoeba. Invest Ophthalmol Vis Sci. 2010;51(13):e-abstract 2428.
International Organization for Standardization (ISO). International Standard ISO 19045:2015: Ophthalmic optics – contact lens care products – method for evaluating acanthamoeba encystment by contact lens care products. First edition 2015-04-01. Geneva: ISO; 2015.
Wilhelmus KR, Osato MS, Font RL, Robinson NM, Jones DB. Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol. 1986;104(9):1309–1312.
Khunkitti W, Lloyd D, Furr JR, Russell AD. The lethal effects of biguanides on cysts and trophozoites of Acanthamoeba castellanii. J Appl Bacteriol. 1996;81(1):73–77.
Hamilton MA, Russo RC, Thurston RV. Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Environ Sci Technol. 1977;11(7):714–719.
Cordingley JS, Wills RA, Villemez CL. Osmolarity is an independent trigger of Acanthamoeba castellanii differentiation. J Cell Biochem. 1996;61(2):167–171.
Ahearn DG, Simmons RB, Ward MA, Stulting RD. Potential resistant morphotypes of Acanthamoeba castellanii expressed in multipurpose contact lens disinfection systems. Eye Contact Lens. 2012;38(6):400–405.
Dudley R, Matin A, Alsam S, Sissons J, Maghsood AH, Khan NA. Acanthamoeba isolates belonging to T1, T2, T3, T4 but not T7 encyst in response to increased osmolarity and cysts do not bind to human corneal epithelial cells. Acta Tropica. 2005;95(2):100–108.
Kliescikova J, Kulda J, Nohynkova E. Stress-induced pseudocyst formation – a newly identified mechanism of protection against organic solvents in acanthamoebae of the T4 genotype. Protist. 2011;162(1): 58–69.
Kliescikova J, Kulda J, Nohynkova E. Propylene glycol and contact-lens solutions containing this diol induce pseudocyst formation in acanthamoebae. Exp Parasitol. 2011;127(1):326–328.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]